Medicare Enrolled
Dr. Nguyet Le-Lindqwister, MD
Hematology & Oncology · Peoria, IL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Le-Lindqwister from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Le-Lindqwister?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Le-Lindqwister
Dr. Nguyet Le-Lindqwister is a hematology & oncology specialist in Peoria, IL, with 21 years of NPI registration. Based on federal Medicare data, Dr. Le-Lindqwister performed 214,701 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Le-Lindqwister received a total of $3,677 from 50 pharmaceutical and/or device companies across 198 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Le-Lindqwister is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 3% volume in IL
$3,677 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗214,701
Medicare services
Top 3% in IL for hematology & oncology
Not available
Unique patients (not deduplicated)
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
41,820 | $0 | $5 |
| Paclitaxel chemotherapy injection | 24,594 | $0 | $2 |
| Azacitidine chemotherapy injection An injection of the medication azacitidine, measured at 1 mg per unit. |
21,800 | $0 | $9 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
16,516 | $0 | $2 |
| Pembrolizumab injection (Keytruda) | 14,000 | $43 | $147 |
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
13,500 | $1 | $4 |
| Denosumab injection (Prolia/Xgeva) | 11,520 | $18 | $56 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
10,300 | $2 | $12 |
| Anti-nausea injection (aprepitant) | 9,100 | $1 | $6 |
| Oxaliplatin chemotherapy injection This procedure involves the administration of oxaliplatin, a chemotherapy medication, via injection. The dosage specified is 0.5 mg. |
7,900 | $0 | $1 |
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
6,200 | $0 | $2 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
4,220 | $0 | $1 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
4,200 | $0 | $4 |
| Trastuzumab biosimilar injection, 10 mg An injection of trastuzumab-qyyp, a biosimilar medication, administered in a 10 mg dose. |
3,333 | $20 | $333 |
| Eflapegrastim injection, 0.1 mg An injection of eflapegrastim-xnst administered at a dose of 0.1 mg. |
2,508 | $25 | $72 |
| Anti-nausea injection (Aloxi/palonosetron) | 2,360 | $1 | $32 |
| Rituximab-pvvr biosimilar injection, 10 mg An injection of rituximab-pvvr, a biosimilar medication, administered in a 10 mg dose. |
1,970 | $23 | $230 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,669 | $8 | $62 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
1,434 | $10 | $83 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,287 | $8 | $26 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
944 | $1 | $2 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
773 | $91 | $314 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
694 | $94 | $674 |
| Anti-nausea injection (ondansetron/Zofran) | 688 | $0 | $1 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
642 | $21 | $150 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
598 | $10 | $122 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
578 | $11 | $106 |
| Injection, leucovorin calcium, per 50 mg | 529 | $3 | $13 |
| Injection, potassium chloride, per 2 meq | 510 | $0 | $1 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
504 | $7 | $53 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 490 | $20 | $164 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
471 | $2 | $26 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
437 | $2 | $10 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
431 | $59 | $223 |
| Pegfilgrastim-apgf injection An injection of pegfilgrastim-apgf, a biosimilar medication. The dose specified is 0.5 mg. |
336 | $87 | $1,011 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
333 | $13 | $107 |
| Iron level test | 320 | $6 | $51 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
316 | $8 | $69 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
282 | $15 | $119 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
266 | $6 | $48 |
| Cyclophosphamide, 100 mg | 264 | $15 | $120 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
230 | $1 | $3 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
226 | $46 | $340 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
221 | $1 | $8 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
186 | $16 | $132 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
185 | $9 | $71 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
179 | $52 | $2,273 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
173 | $15 | $105 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
173 | $48 | $327 |
| Iron dextran injection, 50 mg An injection containing 50 mg of iron dextran administered to the patient. |
168 | $13 | $41 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
167 | $53 | $377 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
161 | $1 | $5 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
137 | $6 | $50 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
135 | $14 | $116 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
125 | $160 | $2,989 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
121 | $21 | $147 |
| Immunoglobulin light chain measurement A blood test that measures the levels of immunoglobulin light chains, which are proteins produced by plasma cells. |
110 | $16 | $70 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
102 | $27 | $271 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
95 | $15 | $101 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
80 | $24 | $272 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
77 | $122 | $538 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
74 | $19 | $267 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
74 | $9 | $103 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
74 | $2 | $19 |
| Serum protein measurement A blood test that measures the total amount of protein in the serum. It helps evaluate overall health and nutritional status. |
69 | $10 | $48 |
| Serum immunofixation test A laboratory test that analyzes a blood serum sample to identify specific abnormal proteins. The procedure uses an immunologic technique to detect and characterize these proteins. |
54 | $21 | $90 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 54 | $133 | $591 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
53 | $25 | $155 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
51 | $17 | $132 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
45 | $10 | $73 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
42 | $198 | $679 |
| Beta-2 microglobulin level test A blood test that measures the level of beta-2 microglobulin, a protein produced by cells in the body. |
41 | $15 | $127 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
40 | $1,074 | $6,750 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
40 | $41 | $294 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
39 | $26 | $192 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 38 | $416 | $926 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
36 | $4 | $21 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 125 | 31 | $20 | $164 |
| PSA test (prostate cancer screening) | 29 | $18 | $145 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
29 | $39 | $136 |
| Blood sample collection from implanted device This procedure involves drawing a blood sample directly from a medical device that has been surgically placed in the body. |
28 | $20 | $100 |
| Phosphate level test A blood test that measures the amount of phosphate in your body. Phosphate is a mineral that helps keep bones and teeth strong. |
17 | $5 | $38 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
17 | $43 | $138 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
14 | $17 | $142 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
12 | $4 | $32 |
| Erythrocyte sedimentation rate (ESR) test A blood test that measures how quickly red blood cells settle in a test tube to detect inflammation in the body. This specific method is performed manually rather than using an automated machine. |
12 | $4 | $28 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
26.8% high complexity
68.6% medium
4.6% routine
Industry Payment Transparency
Open Payments through 2023 ↗$3,677
Total received (2018-2023)
Avg $613/year across 6 years
Top 48% in IL for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
198
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2023
$210
2022
$1,057
2021
$85
2020
$328
2019
$1,035
2018
$962
Payments by company (2023)
AstraZeneca Pharmaceuticals LP
$45
Boehringer Ingelheim Pharmaceuticals, Inc.
$26
Novartis Pharmaceuticals Corporation
$23
Mirati Therapeutics, Inc.
$21
Pharmacyclics LLC, An AbbVie Company
$20
Seagen Inc.
$20
Lilly USA, LLC
$19
Stemline Therapeutics Inc.
$19
G1 Therapeutics, Inc.
$17
Top 3 companies account for 44.4% of 2023 payments
All-time payments by company (2018-2023) ›
Novartis Pharmaceuticals Corporation
$377
PFIZER INC.
$284
Pharmacyclics LLC, An AbbVie Company
$240
Exelixis Inc.
$240
E.R. Squibb & Sons, L.L.C.
$223
AstraZeneca Pharmaceuticals LP
$200
Amgen Inc.
$162
Takeda Pharmaceuticals U.S.A., Inc.
$156
EISAI INC.
$136
Boehringer Ingelheim Pharmaceuticals, Inc.
$111
Merck Sharp & Dohme Corporation
$101
Seattle Genetics, Inc.
$99
Bayer HealthCare Pharmaceuticals Inc.
$97
Lilly USA, LLC
$93
Genentech USA, Inc.
$80
Seagen Inc.
$76
Celgene Corporation
$75
Janssen Biotech, Inc.
$66
GENZYME CORPORATION
$57
Clovis Oncology, Inc.
$55
Incyte Corporation
$55
Gilead Sciences, Inc.
$54
Puma Biotechnology, Inc.
$49
Tosoh Bioscience, Inc.
$48
Janssen Pharmaceuticals, Inc
$48
Pharmacyclics LLC, an AbbVie Company
$36
Merck Sharp & Dohme LLC
$32
Astellas Pharma US Inc
$31
Ipsen Biopharmaceuticals, Inc
$28
ABBVIE INC.
$27
PharmaEssentia USA Corporation
$24
Mirati Therapeutics, Inc.
$21
Rigel Pharmaceuticals, Inc.
$20
Verastem, Inc.
$20
BeiGene USA, Inc.
$20
Agios Pharmaceuticals, Inc.
$19
Jazz Pharmaceuticals Inc.
$19
AbbVie, Inc.
$19
Stemline Therapeutics Inc.
$19
TESARO, Inc.
$19
GlaxoSmithKline, LLC.
$18
G1 Therapeutics, Inc.
$17
Myovant Sciences Inc.
$17
Foundation Medicine, Inc.
$16
Kite Pharma, Inc.
$14
Karyopharm Therapeutics Inc.
$14
SERVIER PHARMACEUTICALS LLC
$14
Deciphera Pharmaceuticals Inc.
$12
ADC Therapeutics America, Inc.
$11
Secura Bio, Inc.
$9
Top 3 companies account for 24.5% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALIMTA · Abraxane · Avastin · BESREMI · BLENREP · BOSULIF · BRUKINSA · Balversa · CALQUENCE · CHANTIX · COSELA · CYRAMZA · Cabometyx · Copiktra · ELIQUIS · ENHERTU · FASLODEX · FER · FOUNDATIONONE · Farydak · GAZYVA · GILOTRIF · IBRANCE · IMBRUVICA · IMFINZI · IRESSA · Imbruvica · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · NINLARO · Nerlynx · Neulasta · Nexavar · Nubeqa · OPDIVO · ORGOVYX · Orserdu · PADCEV · PIQRAY · PLUVICTO · PROMACTA · PYRUKYND · Pomalyst · QINLOCK · REBLOZYL · Rubraca · SCEMBLIX · SOMATULINE DEPOT · ST AIA-PACK · SUTENT · Stivarga · TASIGNA · TECENTRIQ · TIBSOVO · TUKYSA · Tavalisse · Trodelvy · VENCLEXTA · VERZENIO · VOTRIENT · VYXEOS · Venclexta · XALKORI · XARELTO · XPOVIO · Xofigo · Xtandi · ZEJULA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
21
County median income
$64,938
Nearest hospital to ZIP centroid (approximate)
CARLE HEALTH PEKIN HOSPITAL
14.4 mi
14.4 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2023 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Le-Lindqwister is a mixed practice specialist, with above-average Medicare volume (top 3% in IL), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Le-Lindqwister experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Le-Lindqwister performed 41,820 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Le-Lindqwister receive payments from pharmaceutical companies?
Yes. Dr. Le-Lindqwister received a total of $3,677 from 50 companies across 198 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Le-Lindqwister's costs compare to other hematology & oncology specialists in Peoria?
Dr. Le-Lindqwister's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Le-Lindqwister) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Peoria
Browse hematology & oncology specialists in Peoria ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in IL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in IL
Which IL hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Pharmacyclics LLC, An AbbVie Company Payments to Doctors
See all physicians who received payments from Pharmacyclics LLC, An AbbVie Company.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology